| abstract |
The present invention is based on novel discoveries relatingnto ebastine, carebastine, and epinastine hydrochloride.nSpecifically, the present invention relates to the use of ebastinenand carebastine as an inhibitor of (A) T cell proliferation, (B) Th2ntype cytokine production, (C) inflammatory cytokine production, andn(D) T cell migration. In addition, it relates to the use of epinastinenhydrochloride as an inhibitor of (A) T cell proliferation, (B) Th2ntype cytokine production, and (C) Th1 type cytokine production. |